Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ALLOPREGNAN-3ALPHA-OL-20-ONE, also known as Allopregnanolone, is an endogenous inhibitory pregnane neurosteroid synthesized from progesterone. It acts as a positive allosteric modulator of GABAA receptors at nM concentrations, particularly potentiating isoforms containing δ subunits, and of GABAC receptors at μM concentrations. Allopregnanolone exhibits effects similar to other GABAA receptor potentiators, such as benzodiazepines, including potent anticonvulsant, anxiolytic, and sedative activity. It is a neuroactive steroid present in both the blood and the brain.

516-54-1

Post Buying Request

516-54-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

516-54-1 Usage

Uses

Used in Pharmaceutical Industry:
ALLOPREGNAN-3ALPHA-OL-20-ONE is used as a therapeutic agent for its anticonvulsant, anxiolytic, and sedative properties. Its ability to modulate GABAA and GABAC receptors makes it a promising candidate for the treatment of various neurological and psychiatric disorders.
Used in Neurological Applications:
ALLOPREGNAN-3ALPHA-OL-20-ONE is used as a neuroactive steroid for its potent anticonvulsant, anxiolytic, and sedative effects. It helps in the management of seizure disorders, anxiety, and sleep-related issues by enhancing the inhibitory action of GABA in the brain.
Used in Research and Development:
ALLOPREGNAN-3ALPHA-OL-20-ONE is used as a research compound to study the role of neurosteroids in the modulation of GABAergic signaling and their potential applications in the development of new therapeutic strategies for neurological and psychiatric conditions.

References

1) Belelli and Lambert (2005),?Neurosteroids: endogenous regulators of the GABA(A) receptor; Nat. Rev. Neurosci,,?6?565 2) Reddy?et al. (2010),?Neurosteroids: endogenous role in the human brain and therapeutic potentials; Prog. Brain Res.,?186?113 3) Frieder?et al. (2019),?Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development; CNS Drugs,?33?265 4) Balan?et al.?(2019),?Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Proinflammatory Signaling in Macrophages and Brain; Sci. Rep.,?9?1220 5) Chang?et al.?(2019),?Neurosteroid allopregnanolone inhibits glutamate release from rat cerebrocortical nerve terminals; Synapse,?73?e22076 6) Cho?et al.?(2018),?Increased Superoxide Dismutase 2 by Allopregnanolone Ameliorates ROS-Mediated Neuronal Death in Mice with Pilocarpine-Induced Status Epilepticus; Neurochem. Res.,?43?1464

Check Digit Verification of cas no

The CAS Registry Mumber 516-54-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 516-54:
(5*5)+(4*1)+(3*6)+(2*5)+(1*4)=61
61 % 10 = 1
So 516-54-1 is a valid CAS Registry Number.
InChI:InChI=1/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1

516-54-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3α-hydroxy-5α-pregnan-20-one

1.2 Other means of identification

Product number -
Other names (3α)-Allopregnanolone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:516-54-1 SDS

516-54-1Relevant articles and documents

Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: Role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway

Jin, Yi,Mesaros, A. Clementina,Blair, Ian A.,Penning, Trevor M.

experimental part, p. 53 - 61 (2012/06/15)

Active sex hormones such as testosterone and progesterone are metabolized to tetrahydrosteroids in the liver to terminate hormone action. One main metabolic pathway, the 5β-pathway, involves 5β-steroid reductase (AKR1D1, where AKR refers to the aldo-keto reductase superfamily), which catalyses the reduction of the 4-ene structure, and ketosteroid reductases (AKR1C1-AKR1C4), which catalyse the subsequent reduction of the 3-oxo group. The activities of the four human AKR1C enzymes on 5β-dihydrotestosterone, 5β-pregnane-3,20-dione and 20α-hydroxy-5β-pregnan-3-one, the intermediate 5β-dihydrosteroids on the 5β-pathway of testosterone and progesterone metabolism, were investigated. Product characterization by liquid chromatography-MS revealed that the reduction of the 3-oxo group of the three steroids predominantly favoured the formation of the corresponding 3α-hydroxy steroids. The stereochemistry was explained by molecular docking. Kinetic properties of the enzymes identified AKR1C4 as the major enzyme responsible for the hepatic formation of 5β-tetrahydrosteroid of testosterone, but indicated differential routes and roles of human AKR1C for the hepatic formation of 5β-tetrahydrosteroids of progesterone. Comparison of the kinetics of the AKR1C1-AKR1C4-catalysed reactions with those of AKR1D1 suggested that the three intermediate 5β-dihydrosteroids derived from testosterone and progesterone are unlikely to accumulate in liver, and that the identities and levels of 5β-reduced metabolites formed in peripheral tissues will be governed by the local expression of AKR1D1 and AKR1C1-AKR1C3. The Authors Journal compilation 2011 Biochemical Society.

METHODS OF NEUROPROTECTION USING NEUROPROTECTIVE STEROIDS AND A VITAMIN D

-

, (2012/01/03)

Described herein are compositions and methods for treating or preventing nervous system injury. In particular, the methods and compositions relate to the use of at least one neuroprotective steroid, such as progesterone, and vitamin D.

Reduction of steroidal ketones with amine - Boranes

Leontjev,Vasiljeva,Pivnitsky

, p. 703 - 708 (2007/10/03)

Complexes of secondary amines with borane, R2NH·BH 3, surpass sodium borohydride as reducing agents for saturated and unsaturated steroidal 3-, 12-, 17-, and 20-ketones as regards chemo- and regioselectivity and mildness of the reaction conditions. In the case of 12-ketones, stereoselectivity is also improved.

REGIOSELECTIVE REDUCTION OF POLYKETONES ON SILICA GEL SURFACE WITH BORANE-TRIMETHYLAMINE COMPLEX

Gohzu, Shun-ichi,Tada, Masahiro

, p. 61 - 64 (2007/10/02)

Steroidal diones and trione, bicyclic diones (7 and 8) and a tricyclic dione were adsorbed on silica gel and reduced with BH3*NMe3.The carbonyl groups at C-3 of the steroids, at C-4 of 7 and at C-3 of 8 were reduced regioselectively.The FT-IR spectra of 5α- and 5β-androstane-3,17-dione adsorbed on silica gel were measured.

STUDY OF THE DIRECT EFFECT OF LHRH AGONIST ON TESTICULAR 17-HYDROXYLASE AND 5α-REDUCTASE ACTIVITIES IN NON-HYPOPHYSECTOMIZED ADULT RATS TREATED WITH AN ANTI-LUTEINIZING HORMONE SERUM

Carmichael, Rejean,Belanger, Alain

, p. 1 - 12 (2007/10/02)

In order to study both direct and pituitary-mediated mechanisms of action of the LHRH analogue 6, des-Gly-NH210>LHRH ethylamide upon testicular steroidogenesis in adult rat, we compared the effects of the agonist when administered alone or concomitantly with an anti-LH serum to non-hypophysectomized rats.Testicular steroid contents and in vitro progesterone and testosterone metabolism were determined.Anti-LH serum administration was able to prevent 5α-reductase stimulation by the agonistic peptide, but not the inhibition of 17-hydroxylase activity.These data suggest that modulation of 17-hydroxylase involves both direct and pituitary-mediated processes, while 5α-reductase stimulation is mainly if not only due to a pituitary-mediated mechanism.

ANDROGENIC MODULATION OF PROGESTERONE METABOLISM BY RAT GRANULOSA CELLS IN CULTURE

Duleba, Antoni J.,Takahashi, Hideyuki,Moon, Young S.

, p. 321 - 330 (2007/10/02)

Effects of androgens on progesterone accumulation, utilization of exogenous progesterone and accumulation of progesterone metabolites by rat granulosa cells in culture were studied.Androgen increased progesterone accumulation in cultures without exogenous progesterone and slowed the overall decline of progesterone concentration in cultures supplemented with exogenous progesterone.Both aromatizable testosterone and nonaromatizable 5α-dihydrotestosterone decreased progesterone utilization by granulosa cells by 12 to 30percent.This effect was observed irrespective of whether the cells were continuously exposed to androgens or only pre-exposed.In the same experiments, androgens decreased conversion of radiolabeled progesterone to 20α-hydroxy-4-pregnen-3-one by 11 to 50percent and to 5α-pregnane-3α,20α-diol by 26 to 49percent.Accumulation of 3α-hydroxy-5α-pregnan-20-one was not altered in 3 h incubations and was increased by up to 43percent in 24 h incubations by androgen treatment.It is suggested that androgens alter progesterone catabolism by granulosa cells by decreasing 20α-hydroxysteroid dehydrogenase activity and that this effect may contribute to overall stimulatory action of androgens on progesterone accumulation.

METABOLISM AND CONJUGATION OF PROGESTERONE BY BOVINE LIVER AND ADIPOSE TISSUES, IN VITRO

Clemens, J. D.,Estergreen, V. L.

, p. 287 - 306 (2007/10/02)

The ability of bovine liver and fat to metabolize progesterone and also to form glucuronide conjugates with these progestins in vitro was investigated.Tissue supernatants were incubated with progesterone, UDP-glucuronic acid, and a NADPH generating system for 5 hr, at 37 deg C.Steroids were identified by thin-layer chromatography, high performance liquid chromatography, and recrystallization to a constant specific activity.The total original radioactivity which could not be removed by exhaustive ether extraction (presumptive conjugates) was 44.7 +/- 14.2percent in liver, 5.0 +/- 3.6percent in subcutaneous fat, and 3.7 +/- 2.2percent in kidney fat samples.Progestins identified in liver samples include 5β-pregnane-3α,20α-diol (free and conjugate), 5β-pregnane-3α,20β-diol (free and conjugate), 3α-hydroxy-5β-pregnan-20-one (free and conjugate), 3β-hydroxy-5β-pregnan-20-one (free), 5β-pregnane-3,20-dione (free), and progesterone (conjugate).Progestins identified in both the free and conjugate fractions of subcutaneous fat and kidney fat samples include progesterone, 3α-hydroxy-5β-pregnan-20-one, 20β-hydroxy-4-pregnen-3-one, and 20α-hydroxy-4-pregnen-3-one.Differences due to sex of bovine used were noted.These results confirm the ability of bovine liver to readily metabolize progesterone and form glucuronide conjugates of these compounds and suggest that adipose tissues take an active role in these actions in cattle.

TOTAL SYNTHESIS OF (+)-5α-DIHYDROPREGNENOLONE VIA ACETYLENE-CATION CYCLIZATION

Kametani, Tetsuji,Suzuki, Koji,Nemoto, Hideo

, p. 1469 - 1470 (2007/10/02)

The stereoselective total synthesis of (+)-5α-dihydropregnenolone 7 via acetylene-cation cyclization of 6, which was readily prepared from the optically active D-ring aromatic steroid 1, is described.

An analysis of the metabolites of progesterone produced by isolated Sertoli cells at the onset of gametogenesis

Wiebe,Tilbe,Buckingham

, p. 561 - 577 (2007/10/02)

Sertoli cells isolated from 7 day old rats were maintained in culture and incubated with [14C]-progesterone for 20 h. The cells and media were extracted with ether/chloroform and the extracts chromatographed two-dimensionally on TLC and the radioactive metabolites visualized by autoradiography. Nine of the metabolites (constituting about 88% of total metabolite radioactivity) were identified by relative mobilities of the compounds and their derivatives in TLC and GC systems and by recrystallizations with authentic steroids as the following: 20α-hydroxypregn-4-en-3-one, 3α-hydroxy-5α-pregnan-20-one, 5α-pregnane-3α,20α-diol, 17β-hydroxy-5α-androstan-3-one, 5α-pregnane-3,20-dione, 17-hydroxypregn-4-ene-3,20-dione, testosterone, 5α-androstane-3α,17β-diol and androst-4-ene-3,17-dione. Over 71% of the metabolite radioactivity was due to 20α-hydroxypregn-4-en-3-one, the major metabolite. 5α-reduced pregnanes constituted about 12% and C19 steroids comprised about 2.9% of the radioactivity of the metabolites. Calculation of relative steroidogenic enzyme activities from initial reaction rates suggested the following activities in μunits/mg Sertoli cell protein: 20α-hydroxysteroid oxidoreductase (20α-HSO; 7.71), 5α-reductase (4.77), 3α-HSO (3.57), 17α-hydroxylase (0.93), 17β-HSO (0.34) and C17-C20 lyase (0.34). The relatively high rate of steroidogenic enzyme activities in the Sertoli cells of young rats may indicate that Sertoli cells are less dependent on Leydig cell steroidogenesis than has been assumed. Since nearly all the metabolites of progesterone and testosterone are now identified, it is possible to construct a picture of Sertoli cell steroidogenic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 516-54-1